NO134800B - - Google Patents

Download PDF

Info

Publication number: NO134800B
Authority: NO; Norway
Prior art keywords: formula; compound; acid; amine; rats
Prior art date: 1971-07-15

Application number

NO2334/72A

Other languages

English (en)

Norwegian (no)

Other versions

NO134800C (da

Inventor

P Bianchini

E Vitale

G Guerra

G Censoni

Original Assignee

Alfa Farmaceutici Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-07-15

Filing date

1972-06-29

Publication date

1976-09-06

1972-06-29 Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa

1976-09-06 Publication of NO134800B publication Critical patent/NO134800B/no

1976-12-15 Publication of NO134800C publication Critical patent/NO134800C/no

Links

150000001875 compounds Chemical class 0.000 claims description 18
150000001412 amines Chemical class 0.000 claims description 13
239000002904 solvent Substances 0.000 claims description 10
150000003839 salts Chemical class 0.000 claims description 7
238000000034 method Methods 0.000 claims description 5
150000001728 carbonyl compounds Chemical class 0.000 claims description 4
239000007859 condensation product Substances 0.000 claims description 4
229910052736 halogen Inorganic materials 0.000 claims description 4
125000005843 halogen group Chemical group 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims 1
241000700159 Rattus Species 0.000 description 15
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
239000002253 acid Substances 0.000 description 8
238000012360 testing method Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
241000700198 Cavia Species 0.000 description 5
208000025865 Ulcer Diseases 0.000 description 5
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
231100000397 ulcer Toxicity 0.000 description 5
206010052428 Wound Diseases 0.000 description 4
208000027418 Wounds and injury Diseases 0.000 description 4
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
229910000041 hydrogen chloride Inorganic materials 0.000 description 4
229920006395 saturated elastomer Polymers 0.000 description 4
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
231100000456 subacute toxicity Toxicity 0.000 description 4
KISZTEOELCMZPY-UHFFFAOYSA-N 3,3-diphenylpropylamine Chemical compound C=1C=CC=CC=1C(CCN)C1=CC=CC=C1 KISZTEOELCMZPY-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
241000700157 Rattus norvegicus Species 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
-1 aliphatic alcohols Chemical class 0.000 description 3
230000003444 anaesthetic effect Effects 0.000 description 3
230000000202 analgesic effect Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000012458 free base Substances 0.000 description 3
NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Natural products NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
238000010992 reflux Methods 0.000 description 3
239000012265 solid product Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
CUGBKQGQESIBMN-UHFFFAOYSA-N 3-thiophen-2-ylpropan-1-amine Chemical compound NCCCC1=CC=CS1 CUGBKQGQESIBMN-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
230000001663 anti-spastic effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000007665 chronic toxicity Effects 0.000 description 2
231100000160 chronic toxicity Toxicity 0.000 description 2
238000006482 condensation reaction Methods 0.000 description 2
239000012043 crude product Substances 0.000 description 2
GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
210000003754 fetus Anatomy 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
150000002366 halogen compounds Chemical class 0.000 description 2
229960001340 histamine Drugs 0.000 description 2
229910000039 hydrogen halide Inorganic materials 0.000 description 2
239000012433 hydrogen halide Substances 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
239000000203 mixture Substances 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
239000000047 product Substances 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
229940076279 serotonin Drugs 0.000 description 2
229910000033 sodium borohydride Inorganic materials 0.000 description 2
239000012279 sodium borohydride Substances 0.000 description 2
231100000820 toxicity test Toxicity 0.000 description 2
NRTLTGGGUQIRRT-UHFFFAOYSA-N triethylazanium;bromide Chemical compound [Br-].CC[NH+](CC)CC NRTLTGGGUQIRRT-UHFFFAOYSA-N 0.000 description 2
DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
UCCQXCFFHYCLEC-UHFFFAOYSA-N 1-quinolin-2-ylethanone Chemical compound C1=CC=CC2=NC(C(=O)C)=CC=C21 UCCQXCFFHYCLEC-UHFFFAOYSA-N 0.000 description 1
MMZJZOAVHSPESP-UHFFFAOYSA-N 2-(3-bromopropyl)thiophene Chemical compound BrCCCC1=CC=CS1 MMZJZOAVHSPESP-UHFFFAOYSA-N 0.000 description 1
ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
BYNJCCMGUBTMJZ-UHFFFAOYSA-N 3,3-diphenylpropanal Chemical compound C=1C=CC=CC=1C(CC=O)C1=CC=CC=C1 BYNJCCMGUBTMJZ-UHFFFAOYSA-N 0.000 description 1
JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
AZAXFLWCDPQVHO-UHFFFAOYSA-N 3-thiophen-2-ylpropanal Chemical compound O=CCCC1=CC=CS1 AZAXFLWCDPQVHO-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
208000031648 Body Weight Changes Diseases 0.000 description 1
102400000967 Bradykinin Human genes 0.000 description 1
101800004538 Bradykinin Proteins 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
206010055690 Foetal death Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
102400000050 Oxytocin Human genes 0.000 description 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
101800000989 Oxytocin Proteins 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
206010000210 abortion Diseases 0.000 description 1
231100000176 abortion Toxicity 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
239000003420 antiserotonin agent Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
150000008378 aryl ethers Chemical class 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000004579 body weight change Effects 0.000 description 1
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
230000032692 embryo implantation Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
231100001048 fetal toxicity Toxicity 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
229940071870 hydroiodic acid Drugs 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000004899 motility Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
229960001723 oxytocin Drugs 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000008855 peristalsis Effects 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
229940005657 pyrophosphoric acid Drugs 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
230000009103 reabsorption Effects 0.000 description 1
230000011514 reflex Effects 0.000 description 1
BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
229960003147 reserpine Drugs 0.000 description 1
MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000002048 spasmolytic effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002110 toxicologic effect Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
238000002562 urinalysis Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO2334/72A 1971-07-15 1972-06-29 NO134800C (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT347671		1971-07-15

Publications (2)

Publication Number	Publication Date
NO134800B true NO134800B (da)	1976-09-06
NO134800C NO134800C (da)	1976-12-15

Family

ID=11108082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO2334/72A NO134800C (da)	1971-07-15	1972-06-29

Country Status (17)

Country	Link
JP (1)	JPS5224012B1 (da)
AR (4)	AR197088A1 (da)
AT (2)	AT318560B (da)
BE (1)	BE786147A (da)
BR (1)	BR7204677D0 (da)
CA (1)	CA1003859A (da)
CH (2)	CH582138A5 (da)
DK (1)	DK133298C (da)
ES (4)	ES404743A1 (da)
FI (1)	FI57100C (da)
FR (1)	FR2145639B1 (da)
GB (1)	GB1345319A (da)
MX (1)	MX3738E (da)
NL (1)	NL153862B (da)
NO (1)	NO134800C (da)
SE (1)	SE388607B (da)
ZA (1)	ZA724511B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1080455B (it) *	1977-06-17	1985-05-16	Alfa Farmaceutici Spa	N 3 feniltiopropil 3.3 difenil propilammine sostituite dotate di attivita farmacologia

1972
- 1972-06-29 NO NO2334/72A patent/NO134800C/no unknown
- 1972-06-30 ZA ZA724511A patent/ZA724511B/xx unknown
- 1972-07-07 FI FI1946/72A patent/FI57100C/fi active
- 1972-07-10 CH CH1031172A patent/CH582138A5/xx not_active IP Right Cessation
- 1972-07-10 CH CH1314575A patent/CH589618A5/xx not_active IP Right Cessation
- 1972-07-11 ES ES404743A patent/ES404743A1/es not_active Expired
- 1972-07-12 FR FR7225278A patent/FR2145639B1/fr not_active Expired
- 1972-07-12 MX MX72570U patent/MX3738E/es unknown
- 1972-07-12 BE BE786147A patent/BE786147A/xx unknown
- 1972-07-14 NL NL727209820A patent/NL153862B/xx not_active IP Right Cessation
- 1972-07-14 DK DK352272A patent/DK133298C/da active
- 1972-07-14 AT AT607272A patent/AT318560B/de not_active IP Right Cessation
- 1972-07-14 SE SE7209286A patent/SE388607B/xx unknown
- 1972-07-14 AT AT979273A patent/AT321272B/de not_active Expired
- 1972-07-14 CA CA147,175A patent/CA1003859A/en not_active Expired
- 1972-07-14 JP JP47070048A patent/JPS5224012B1/ja active Pending
- 1972-07-14 BR BR4677/72A patent/BR7204677D0/pt unknown
- 1972-07-17 AR AR243108A patent/AR197088A1/es active
- 1972-07-17 GB GB3338072A patent/GB1345319A/en not_active Expired
1973
- 1973-08-03 AR AR249438A patent/AR197153A1/es active
- 1973-08-03 AR AR249439A patent/AR197154A1/es active
- 1973-08-03 AR AR249440A patent/AR197155A1/es active
1975
- 1975-01-28 ES ES434220A patent/ES434220A1/es not_active Expired
- 1975-01-28 ES ES434221A patent/ES434221A1/es not_active Expired
- 1975-01-28 ES ES434219A patent/ES434219A1/es not_active Expired

Also Published As

Publication number	Publication date
FI57100B (fi)	1980-02-29
AR197154A1 (es)	1974-03-15
AT318560B (de)	1974-10-25
DE2232939B2 (de)	1975-10-02
ES434220A1 (es)	1976-12-16
CH589618A5 (da)	1977-07-15
ZA724511B (en)	1973-03-28
DE2232939A1 (de)	1973-01-18
SE388607B (sv)	1976-10-11
CH582138A5 (da)	1976-11-30
FR2145639A1 (da)	1973-02-23
NL153862B (nl)	1977-07-15
AR197155A1 (es)	1974-03-15
BE786147A (fr)	1972-11-03
NO134800C (da)	1976-12-15
AR197088A1 (es)	1974-03-15
ES434221A1 (es)	1976-12-01
GB1345319A (en)	1974-01-30
AT321272B (de)	1975-03-25
BR7204677D0 (pt)	1973-11-01
FR2145639B1 (da)	1976-03-05
JPS5224012B1 (da)	1977-06-28
FI57100C (fi)	1980-06-10
AR197153A1 (es)	1974-03-15
DK133298C (da)	1976-09-20
NL7209820A (da)	1973-01-17
ES404743A1 (es)	1976-01-01
CA1003859A (en)	1977-01-18
DK133298B (da)	1976-04-26
ES434219A1 (es)	1976-12-01
MX3738E (es)	1981-06-05

Publication	Publication Date	Title
AU2016349080B2 (en)	2019-03-14	7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
SU1248533A3 (ru)	1986-07-30	Способ получени сульфамоилзамещенных производных фенэтиламина или его сол нокислой соли
FI64154C (fi)	1983-10-10	Foerfarande foer framstaellning av en terapeutiskt verkande 5-etyl-isoxazol-4-karboxylsyra-(4-trifluormetyl)-anilid
FI88504B (fi)	1993-02-15	Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat
DE69331171T2 (de)	2002-07-11	Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
US3047462A (en)	1962-07-31	Quinazolone anti-inflammatory composition
Melloni et al.	1972	Synthesis and antiprotozoal activity of methylnitro derivatives of 2, 2'-biimidazole
WO2001083487A1 (fr)	2001-11-08	Derive de froindazole
JP2004513126A (ja)	2004-04-30	窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
US3560566A (en)	1971-02-02	Diphenyl-ureas,-thioureas,-guanidines and -parabanic acids
DE1913199B2 (de)	1975-01-16	Mannichbasen aus alpha-Tetralon bzw. dessen Derivaten und Arylalkylaminen und deren Salze
NO134800B (da)	1976-09-06
Grover et al.	1965	New Antifertility Agents. 2, 3-Diphenylbenzofurans1a
CA1082196A (fr)	1980-07-22	Procede de preparation de nouveaux derives de la phenyl-piperidine et leurs sels
NO883263L (no)	1989-01-24	Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater.
EP0139627B1 (de)	1991-05-22	Verfahren zur Herstellung von neuen in 5-Stellung substituierten 5,10-Dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-onen
Buchman et al.	1946	Potential Antimalarials.(Chloro-2-phenylquinolyl-4)-α-piperidylcarbinols1
NO126022B (da)	1972-12-11
US2983736A (en)	1961-05-09	Process for the preparation of 20-alkylamino steroid derivatives and novel 20-alkylamino steroid derivatives prepared thereby
JPS5810387B2 (ja)	1983-02-25	４，５，６，７テトラヒドロイミダゾ〔４，５−ｃ〕ピリジン誘導体及びその製法
Loynes et al.	1965	New sulfonamides
DE829894C (de)	1952-01-31	Verfahren zur Herstellung neuer Derivate von 1, 8-Naphthyridin-4-carbonsaeuren
SU1093249A3 (ru)	1984-05-15	Способ получени производных аповинкаминола или их фармацевтически приемлемых солей
US3884939A (en)	1975-05-20	1,1-Diphenyl-1{40 -phenylthio-di-propylamine and the salts thereof
KR810000431B1 (ko)	1981-05-01	치환된 2-(2-하이드록시에틸)-테트라하이드로-1, 4-옥사진의 제조방법